Clincosm LogoSign in Get a demo

Recurrent Adult Acute Myeloid Leukemia

Showing 51 - 75 of 131
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Adult Acute Myeloid Leukemia Trial in Winston-Salem (Vincristine Sulfate Liposome, Laboratory Biomarker Analysis)

Terminated
Has Results
  • Recurrent Adult Acute Myeloid Leukemia
  • Vincristine Sulfate Liposome
  • Laboratory Biomarker Analysis
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 31, 2019

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
Has Results
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +13 more
  • Stanford, California
  • +3 more
May 2, 2019

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Terminated
Has Results
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +14 more
  • Stanford, California
    Stanford University Cancer Institute
Apr 1, 2019

Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid

Completed
  • Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
  • +33 more
  • therapeutic allogeneic lymphocytes
  • Stanford, California
    Stanford University
Mar 16, 2019

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +17 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Feb 27, 2019

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Terminated
Has Results
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +110 more
  • Omaha, Nebraska
    University of Nebraska Medical Center
Feb 6, 2019

Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in Kennewick, Kirkland, Seattle

Completed
Has Results
  • Previously Treated Myelodysplastic Syndrome
  • Recurrent Adult Acute Myeloid Leukemia
  • Kennewick, Washington
  • +2 more
Feb 5, 2019

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Terminated
Has Results
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +16 more
  • metformin hydrochloride
  • +2 more
  • Chicago, Illinois
    Northwestern University
Jan 8, 2019

Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Therapy-Related Acute Myeloid Leukemia Trial in

Completed
  • Recurrent Adult Acute Myeloid Leukemia
  • +3 more
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Jan 23, 2019

Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid

Completed
Has Results
  • Adult Acute Erythroid Leukemia (M6)
  • +15 more
  • liposomal cytarabine-daunorubicin CPX-351
  • Stanford, California
    Stanford University, School of Medicine
Jan 17, 2019

Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Cleveland (ixazomib, mitoxantrone HCl,

Completed
  • Recurrent Adult Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Cleveland, Ohio
  • +1 more
Dec 12, 2018

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Terminated
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +14 more
  • Stanford, California
    Stanford University, School of Medicine
Oct 25, 2018

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute

Terminated
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +13 more
  • ipilimumab
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Sep 4, 2018

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
Has Results
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +14 more
  • Akt inhibitor MK2206
  • laboratory biomarker analysis
  • Houston, Texas
  • +1 more
Jul 27, 2018

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

Completed
Has Results
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +117 more
  • Ann Arbor, Michigan
    University of Michigan University Hospital
Jun 28, 2018

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
Has Results
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +18 more
  • antitumor drug screening assay
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jun 13, 2018

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Completed
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +6 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jun 29, 2018

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Withdrawn
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +7 more
  • gemtuzumab ozogamicin
  • laboratory biomarker analysis
  • (no location specified)
Jun 29, 2018

Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation

Completed
Has Results
  • Adult Acute Monoblastic Leukemia (M5a)
  • +21 more
  • Birmingham, Alabama
  • +81 more
May 21, 2018

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Withdrawn
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +14 more
  • arsenic trioxide
  • laboratory biomarker analysis
  • (no location specified)
May 16, 2018

Recurrent Adult Acute Myeloid Leukemia Trial in Palo Alto (Cytarabine, Ibrutinib, Idarubicin)

Terminated
  • Recurrent Adult Acute Myeloid Leukemia
  • Palo Alto, California
    Stanford University, School of Medicine
May 7, 2018

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia, Adult Acute

Completed
Has Results
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +16 more
  • Birmingham, Alabama
  • +340 more
Mar 20, 2018

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Completed
Has Results
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +7 more
  • Duarte, California
    City of Hope
Mar 19, 2018

Recurrent Adult Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia Trial in Chicago, Baltimore, Houston (Akt

Terminated
Has Results
  • Recurrent Adult Acute Myeloid Leukemia
  • Untreated Adult Acute Myeloid Leukemia
  • Akt Inhibitor GSK2141795
  • +2 more
  • Chicago, Illinois
  • +2 more
Apr 4, 2018

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Completed
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +7 more
  • mitoxantrone hydrochloride
  • +5 more
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Apr 2, 2018